Cresco Labs (CRLBF) Operating Leases (2019 - 2026)

Cresco Labs' (CRLBF) quarterly Operating Leases came in at $127.2 million in Q1 2026, up 1.15% on a QoQ basis from $125.7 million in Q4 2025.

Cresco Labs (CRLBF) Operating Leases (2019 - 2026) Analysis & Trends

Cresco Labs (CRLBF) has 8 years of Operating Leases data on file, last reported at $127.2 million in Q1 2026.

Quarterly Operating Leases changed N/A year-over-year to $127.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $127.2 million (changed N/A YoY) and the FY2025 annual result came in at $125.7 million, changed N/A from the prior year.
Operating Leases grew to $127.2 million in Q1 2026, from $125.7 million in the prior quarter.
In the past five years, Operating Leases ranged from a high of $173.3 million in Q4 2022 to a low of $124.1 million in Q1 2022.
A 5-year average of $149.5 million and a median of $159.1 million in 2024 frame the typical range for Operating Leases.
Annual changes were most pronounced in 2022 — Operating Leases surged 61.94% — and 2023, when it retreated 5.5%.
Tracing CRLBF's Operating Leases over 5 years: stood at $173.3 million in 2022, then fell by 5.5% to $163.8 million in 2023, then retreated by 3.74% to $157.7 million in 2024, then decreased by 20.26% to $125.7 million in 2025, then climbed by 1.15% to $127.2 million in 2026.
The last three Operating Leases figures came in at $127.2 million (Q1 2026), $125.7 million (Q4 2025), and $157.7 million (Q3 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.85 Bn	42.88 Bn	-
2	Teva Pharmaceutical Industries	43.02 Bn	39.37 Bn	2.15 Bn
3	Zoetis	31.47 Bn	29.79 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.59 Bn	22.79 Bn	5.10 Bn
5	United Therapeutics	22.20 Bn	19.53 Bn	683.80 Mn
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn
7	Neurocrine Biosciences	15.45 Bn	15.06 Bn	935.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.10 Bn	9.94 Bn	-
10	Cresco Labs	290.46 Mn	226.34 Mn	86.95 Mn

Download Data